nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCC2—Rifampicin—leprosy	0.56	0.754	CbGbCtD
Sparfloxacin—ABCB1—Rifampicin—leprosy	0.183	0.246	CbGbCtD
Sparfloxacin—Lacrimal structural disorder—Thalidomide—leprosy	0.00739	0.0295	CcSEcCtD
Sparfloxacin—TOP2A—Menadione—Thalidomide—leprosy	0.0066	1	CbGdCrCtD
Sparfloxacin—Albuminuria—Dapsone—leprosy	0.00568	0.0227	CcSEcCtD
Sparfloxacin—Intestinal perforation—Thalidomide—leprosy	0.0055	0.0219	CcSEcCtD
Sparfloxacin—Fungal skin infection—Thalidomide—leprosy	0.0052	0.0208	CcSEcCtD
Sparfloxacin—Erythema nodosum—Thalidomide—leprosy	0.00502	0.0201	CcSEcCtD
Sparfloxacin—Lacrimal disorder—Thalidomide—leprosy	0.00486	0.0194	CcSEcCtD
Sparfloxacin—Peripheral vascular disorder—Thalidomide—leprosy	0.00443	0.0177	CcSEcCtD
Sparfloxacin—Sinus bradycardia—Thalidomide—leprosy	0.00443	0.0177	CcSEcCtD
Sparfloxacin—Vesiculobullous rash—Thalidomide—leprosy	0.00388	0.0155	CcSEcCtD
Sparfloxacin—Oral candidiasis—Thalidomide—leprosy	0.00342	0.0137	CcSEcCtD
Sparfloxacin—Embolism—Thalidomide—leprosy	0.00338	0.0135	CcSEcCtD
Sparfloxacin—Tooth disorder—Thalidomide—leprosy	0.00335	0.0134	CcSEcCtD
Sparfloxacin—Interstitial lung disease—Thalidomide—leprosy	0.00307	0.0123	CcSEcCtD
Sparfloxacin—Cyanosis—Thalidomide—leprosy	0.00307	0.0123	CcSEcCtD
Sparfloxacin—Lung disorder—Thalidomide—leprosy	0.00307	0.0123	CcSEcCtD
Sparfloxacin—Nystagmus—Thalidomide—leprosy	0.00304	0.0121	CcSEcCtD
Sparfloxacin—Metrorrhagia—Thalidomide—leprosy	0.00304	0.0121	CcSEcCtD
Sparfloxacin—Psychotic disorder—Dapsone—leprosy	0.00301	0.012	CcSEcCtD
Sparfloxacin—Albuminuria—Thalidomide—leprosy	0.00291	0.0116	CcSEcCtD
Sparfloxacin—Amblyopia—Thalidomide—leprosy	0.00281	0.0112	CcSEcCtD
Sparfloxacin—Hyperaesthesia—Thalidomide—leprosy	0.00277	0.0111	CcSEcCtD
Sparfloxacin—Rash pustular—Thalidomide—leprosy	0.00272	0.0109	CcSEcCtD
Sparfloxacin—Petechiae—Thalidomide—leprosy	0.00264	0.0105	CcSEcCtD
Sparfloxacin—Numbness—Thalidomide—leprosy	0.00262	0.0105	CcSEcCtD
Sparfloxacin—Pancreatitis—Dapsone—leprosy	0.00261	0.0104	CcSEcCtD
Sparfloxacin—Sensory loss—Thalidomide—leprosy	0.00251	0.01	CcSEcCtD
Sparfloxacin—Accidental injury—Thalidomide—leprosy	0.00246	0.0098	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Dapsone—leprosy	0.00243	0.0097	CcSEcCtD
Sparfloxacin—Skin discolouration—Thalidomide—leprosy	0.00241	0.0096	CcSEcCtD
Sparfloxacin—Arthropathy—Thalidomide—leprosy	0.00239	0.00954	CcSEcCtD
Sparfloxacin—Cellulitis—Thalidomide—leprosy	0.00239	0.00954	CcSEcCtD
Sparfloxacin—Thinking abnormal—Thalidomide—leprosy	0.00237	0.00948	CcSEcCtD
Sparfloxacin—Herpes simplex—Thalidomide—leprosy	0.00236	0.00941	CcSEcCtD
Sparfloxacin—Sinusitis—Dapsone—leprosy	0.00223	0.00889	CcSEcCtD
Sparfloxacin—Gait disturbance—Thalidomide—leprosy	0.00223	0.00889	CcSEcCtD
Sparfloxacin—Neck pain—Thalidomide—leprosy	0.0022	0.00878	CcSEcCtD
Sparfloxacin—Pharyngitis—Dapsone—leprosy	0.00211	0.00845	CcSEcCtD
Sparfloxacin—Candida infection—Thalidomide—leprosy	0.00207	0.00828	CcSEcCtD
Sparfloxacin—Tinnitus—Dapsone—leprosy	0.00199	0.00793	CcSEcCtD
Sparfloxacin—Rash maculo-papular—Thalidomide—leprosy	0.00197	0.00788	CcSEcCtD
Sparfloxacin—Lightheadedness—Thalidomide—leprosy	0.00194	0.00776	CcSEcCtD
Sparfloxacin—Pulmonary oedema—Thalidomide—leprosy	0.00193	0.00772	CcSEcCtD
Sparfloxacin—Hyperkinesia—Thalidomide—leprosy	0.00189	0.00756	CcSEcCtD
Sparfloxacin—Mental disability—Thalidomide—leprosy	0.00189	0.00753	CcSEcCtD
Sparfloxacin—Euphoric mood—Thalidomide—leprosy	0.00187	0.00745	CcSEcCtD
Sparfloxacin—Lymphadenopathy—Thalidomide—leprosy	0.00185	0.00738	CcSEcCtD
Sparfloxacin—Gastroenteritis—Thalidomide—leprosy	0.00178	0.0071	CcSEcCtD
Sparfloxacin—Eye pain—Thalidomide—leprosy	0.00175	0.00697	CcSEcCtD
Sparfloxacin—Injury—Thalidomide—leprosy	0.00172	0.00685	CcSEcCtD
Sparfloxacin—Renal failure acute—Thalidomide—leprosy	0.00171	0.00682	CcSEcCtD
Sparfloxacin—Increased appetite—Thalidomide—leprosy	0.00168	0.0067	CcSEcCtD
Sparfloxacin—Amnesia—Thalidomide—leprosy	0.00168	0.0067	CcSEcCtD
Sparfloxacin—Dermatitis exfoliative—Thalidomide—leprosy	0.00167	0.00667	CcSEcCtD
Sparfloxacin—Vertigo—Dapsone—leprosy	0.00167	0.00665	CcSEcCtD
Sparfloxacin—Atrial fibrillation—Thalidomide—leprosy	0.00166	0.00664	CcSEcCtD
Sparfloxacin—Dermatitis bullous—Thalidomide—leprosy	0.00165	0.00659	CcSEcCtD
Sparfloxacin—Arthritis—Thalidomide—leprosy	0.00162	0.00648	CcSEcCtD
Sparfloxacin—Cough—Dapsone—leprosy	0.00162	0.00646	CcSEcCtD
Sparfloxacin—Diplopia—Thalidomide—leprosy	0.00158	0.0063	CcSEcCtD
Sparfloxacin—Osteoarthritis—Thalidomide—leprosy	0.00158	0.0063	CcSEcCtD
Sparfloxacin—Affect lability—Thalidomide—leprosy	0.00155	0.0062	CcSEcCtD
Sparfloxacin—Migraine—Thalidomide—leprosy	0.00155	0.0062	CcSEcCtD
Sparfloxacin—Psychotic disorder—Thalidomide—leprosy	0.00154	0.00615	CcSEcCtD
Sparfloxacin—Face oedema—Thalidomide—leprosy	0.00152	0.00608	CcSEcCtD
Sparfloxacin—Mood swings—Thalidomide—leprosy	0.00149	0.00596	CcSEcCtD
Sparfloxacin—Ataxia—Thalidomide—leprosy	0.00148	0.00592	CcSEcCtD
Sparfloxacin—Tachycardia—Dapsone—leprosy	0.00148	0.0059	CcSEcCtD
Sparfloxacin—Dry skin—Thalidomide—leprosy	0.00145	0.00577	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Thalidomide—leprosy	0.00144	0.00575	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00142	0.00567	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Thalidomide—leprosy	0.00139	0.00555	CcSEcCtD
Sparfloxacin—Insomnia—Dapsone—leprosy	0.00137	0.00547	CcSEcCtD
Sparfloxacin—Pancreatitis—Thalidomide—leprosy	0.00134	0.00534	CcSEcCtD
Sparfloxacin—Angina pectoris—Thalidomide—leprosy	0.00133	0.0053	CcSEcCtD
Sparfloxacin—Bronchitis—Thalidomide—leprosy	0.00131	0.00523	CcSEcCtD
Sparfloxacin—Pancytopenia—Thalidomide—leprosy	0.00129	0.00517	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Thalidomide—leprosy	0.00124	0.00497	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Dapsone—leprosy	0.00124	0.00494	CcSEcCtD
Sparfloxacin—Pneumonia—Thalidomide—leprosy	0.00122	0.00488	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.0012	0.00481	CcSEcCtD
Sparfloxacin—Abdominal pain—Dapsone—leprosy	0.0012	0.00478	CcSEcCtD
Sparfloxacin—Body temperature increased—Dapsone—leprosy	0.0012	0.00478	CcSEcCtD
Sparfloxacin—Stomatitis—Thalidomide—leprosy	0.00118	0.00473	CcSEcCtD
Sparfloxacin—Conjunctivitis—Thalidomide—leprosy	0.00118	0.00472	CcSEcCtD
Sparfloxacin—Sweating—Thalidomide—leprosy	0.00116	0.00465	CcSEcCtD
Sparfloxacin—Haematuria—Thalidomide—leprosy	0.00116	0.00463	CcSEcCtD
Sparfloxacin—Epistaxis—Thalidomide—leprosy	0.00115	0.00458	CcSEcCtD
Sparfloxacin—Sinusitis—Thalidomide—leprosy	0.00114	0.00455	CcSEcCtD
Sparfloxacin—Agranulocytosis—Thalidomide—leprosy	0.00113	0.00453	CcSEcCtD
Sparfloxacin—Rhinitis—Thalidomide—leprosy	0.00109	0.00437	CcSEcCtD
Sparfloxacin—Hepatitis—Thalidomide—leprosy	0.00109	0.00436	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Thalidomide—leprosy	0.00109	0.00433	CcSEcCtD
Sparfloxacin—Pharyngitis—Thalidomide—leprosy	0.00108	0.00432	CcSEcCtD
Sparfloxacin—Oedema peripheral—Thalidomide—leprosy	0.00107	0.00429	CcSEcCtD
Sparfloxacin—Erythema multiforme—Thalidomide—leprosy	0.00103	0.00412	CcSEcCtD
Sparfloxacin—Tinnitus—Thalidomide—leprosy	0.00102	0.00406	CcSEcCtD
Sparfloxacin—Chills—Thalidomide—leprosy	0.000979	0.00391	CcSEcCtD
Sparfloxacin—Arrhythmia—Thalidomide—leprosy	0.000975	0.00389	CcSEcCtD
Sparfloxacin—Alopecia—Thalidomide—leprosy	0.000964	0.00385	CcSEcCtD
Sparfloxacin—Vomiting—Dapsone—leprosy	0.000963	0.00384	CcSEcCtD
Sparfloxacin—Headache—Dapsone—leprosy	0.000948	0.00379	CcSEcCtD
Sparfloxacin—Flatulence—Thalidomide—leprosy	0.000936	0.00374	CcSEcCtD
Sparfloxacin—Tension—Thalidomide—leprosy	0.000932	0.00372	CcSEcCtD
Sparfloxacin—Dysgeusia—Thalidomide—leprosy	0.00093	0.00371	CcSEcCtD
Sparfloxacin—Nervousness—Thalidomide—leprosy	0.000922	0.00368	CcSEcCtD
Sparfloxacin—Back pain—Thalidomide—leprosy	0.000919	0.00367	CcSEcCtD
Sparfloxacin—Nausea—Dapsone—leprosy	0.000899	0.00359	CcSEcCtD
Sparfloxacin—Tremor—Thalidomide—leprosy	0.00089	0.00355	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Thalidomide—leprosy	0.000881	0.00352	CcSEcCtD
Sparfloxacin—Agitation—Thalidomide—leprosy	0.000873	0.00348	CcSEcCtD
Sparfloxacin—Angioedema—Thalidomide—leprosy	0.000868	0.00346	CcSEcCtD
Sparfloxacin—Malaise—Thalidomide—leprosy	0.000856	0.00342	CcSEcCtD
Sparfloxacin—Vertigo—Thalidomide—leprosy	0.000853	0.00341	CcSEcCtD
Sparfloxacin—Palpitations—Thalidomide—leprosy	0.000839	0.00335	CcSEcCtD
Sparfloxacin—Cough—Thalidomide—leprosy	0.000829	0.00331	CcSEcCtD
Sparfloxacin—Convulsion—Thalidomide—leprosy	0.000823	0.00329	CcSEcCtD
Sparfloxacin—Hypertension—Thalidomide—leprosy	0.00082	0.00327	CcSEcCtD
Sparfloxacin—Arthralgia—Thalidomide—leprosy	0.000808	0.00323	CcSEcCtD
Sparfloxacin—Myalgia—Thalidomide—leprosy	0.000808	0.00323	CcSEcCtD
Sparfloxacin—Chest pain—Thalidomide—leprosy	0.000808	0.00323	CcSEcCtD
Sparfloxacin—Anxiety—Thalidomide—leprosy	0.000806	0.00322	CcSEcCtD
Sparfloxacin—Discomfort—Thalidomide—leprosy	0.000799	0.00319	CcSEcCtD
Sparfloxacin—Dry mouth—Thalidomide—leprosy	0.000791	0.00316	CcSEcCtD
Sparfloxacin—Confusional state—Thalidomide—leprosy	0.000781	0.00312	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Thalidomide—leprosy	0.000759	0.00303	CcSEcCtD
Sparfloxacin—Tachycardia—Thalidomide—leprosy	0.000756	0.00302	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Thalidomide—leprosy	0.000749	0.00299	CcSEcCtD
Sparfloxacin—Anorexia—Thalidomide—leprosy	0.000739	0.00295	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000706	0.00282	CcSEcCtD
Sparfloxacin—Insomnia—Thalidomide—leprosy	0.000701	0.0028	CcSEcCtD
Sparfloxacin—Paraesthesia—Thalidomide—leprosy	0.000696	0.00278	CcSEcCtD
Sparfloxacin—Dyspnoea—Thalidomide—leprosy	0.000691	0.00276	CcSEcCtD
Sparfloxacin—Somnolence—Thalidomide—leprosy	0.000689	0.00275	CcSEcCtD
Sparfloxacin—Dyspepsia—Thalidomide—leprosy	0.000682	0.00272	CcSEcCtD
Sparfloxacin—Decreased appetite—Thalidomide—leprosy	0.000674	0.00269	CcSEcCtD
Sparfloxacin—Pain—Thalidomide—leprosy	0.000663	0.00265	CcSEcCtD
Sparfloxacin—Constipation—Thalidomide—leprosy	0.000663	0.00265	CcSEcCtD
Sparfloxacin—Feeling abnormal—Thalidomide—leprosy	0.000639	0.00255	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Thalidomide—leprosy	0.000634	0.00253	CcSEcCtD
Sparfloxacin—Urticaria—Thalidomide—leprosy	0.000616	0.00246	CcSEcCtD
Sparfloxacin—Abdominal pain—Thalidomide—leprosy	0.000613	0.00245	CcSEcCtD
Sparfloxacin—Body temperature increased—Thalidomide—leprosy	0.000613	0.00245	CcSEcCtD
Sparfloxacin—Hypersensitivity—Thalidomide—leprosy	0.000571	0.00228	CcSEcCtD
Sparfloxacin—Asthenia—Thalidomide—leprosy	0.000556	0.00222	CcSEcCtD
Sparfloxacin—Pruritus—Thalidomide—leprosy	0.000548	0.00219	CcSEcCtD
Sparfloxacin—Diarrhoea—Thalidomide—leprosy	0.00053	0.00212	CcSEcCtD
Sparfloxacin—Dizziness—Thalidomide—leprosy	0.000513	0.00205	CcSEcCtD
Sparfloxacin—Vomiting—Thalidomide—leprosy	0.000493	0.00197	CcSEcCtD
Sparfloxacin—Rash—Thalidomide—leprosy	0.000489	0.00195	CcSEcCtD
Sparfloxacin—Dermatitis—Thalidomide—leprosy	0.000488	0.00195	CcSEcCtD
Sparfloxacin—Headache—Thalidomide—leprosy	0.000486	0.00194	CcSEcCtD
Sparfloxacin—Nausea—Thalidomide—leprosy	0.00046	0.00184	CcSEcCtD
